Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial

Abstract

Objective: Dietary counseling and intervention based on application of conventional criteria have been ineffective in preventing the progressive weight loss associated with HIV infection. The aim of the study was to compare the progression of clinical and nutritional indicators during nutritional supplementation with or without an enterotropic peptide-based formula enriched with n-3 fatty acids.

Design: Randomized trial.

Setting: Tertiary care.

Subjects: Ninety-one patients were screened for the study. Twenty-three did not meet the inclusion criteria, therefore 74 patients were randomized. Of these, 38 were randomized to group I (standard formula) and 36 were randomized to group II supplementation (enterotropic peptide-based formula enriched with n-3 fatty acids).

Interventions: Group I received standard enteral formula and group II received a enterotropic peptide-based enteral formula. The volume was the same (3 cans/day, 236 ml per can). In both groups enteral supplementation were recommended in conjunction with a registered dietitian under a dietary counseling program based on standard nutrition principles. Patients received a prospective serial assessment of nutrition status, nutritional intake with 24 h written food records, GI symptoms, immune function, anthropometric status and intercurrent health events including infections and hospitalization. These determinations were performed at baseline and at 3 months.

Results: Treatment with both supplements resulted in a significant and sustained increase in weight (3.2% in group I and 3.1% in group II); this increase was mostly due to fat mass (12.8% in group I) and (7.5% in group II). Total body water and fat free-mass remained unchanged. CD4 counts remained stable in group I, while a significant increase was detected in group II (576±403 vs 642±394 cells/mm3; P<0.05). After the 3 month period CD4 counts remained higher in group II. Hospitalization events (infections) were also followed during the 3 month period. Group II had fewer hospitalizations than group I, but no statistical differences were found.

Conclusions: Oral nutritional supplements for a 3 month period were well tolerated and resulted in body weight gain in HIV-infected patients. Supplement-enriched formula, with peptides and n-3 fatty acids, increased CD4 count.

European Journal of Clinical Nutrition (2001) 55, 1048–1052

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Alvarez J, Planas M, Martin T, Hernandez C, Sanz J, Chacon P, Bellido D, Moreno F & Arancil FJ (2000) Supplementation in HIV patients in the highly active antiretoviral therapy Clin. Nutr. 19 (A40), 1 0

    Google Scholar 

  • Centers for Disease Control and Prevention (1992) Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults M.M.W.R. 41 (RR-17), 1–19

  • Chlebowski RT, Grosvenor M & Tai V (1991) Dietary fat intake, serum lipids and immunologic status in patients with HIV infection Am. J. Clin. Nutr. 53 1 5

    Article  Google Scholar 

  • Chlebowski RT, Beall G, Grosvenor M, Lillington L, Weintraub N, Ambler C & Richards E (1993) Long term effects of early nutritional support with new enterotropic peptide based formula vs standard enteral formula in HIV-infected patients: randomized prospective trial Nutrition 9 507–512

    CAS  PubMed  Google Scholar 

  • Clark RH, Feleke GF, Din M, Yasmin T, Singh G, Khan FA & Rathmacher JA (2000) Nutritional treatment for acquired immunodeficiency virus associated wasting using B-hydroxy B methylbutyrate, glutamine, and arginine: a randomized, double blind, placebo controlled study J. Parent. Enter. Nutr. 24 133–139

    Article  CAS  Google Scholar 

  • Endres S, Ghorbani R & Keley VE (1989) The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and TNf alpha by mononuclear cells New Engl. J. Med. 320 265–268

    Article  CAS  Google Scholar 

  • Greene JB (1988) Clinical approach to weight loss in the patient with HIV infection Gastroenterol. Clin. N. Am. 17 573–586

    CAS  Google Scholar 

  • Guenter PA, Muurahainen N, Cohan GR, Turner JL & Mullen JL (1992) Relationship between nutritional status, CD4 counts ad survival in HIV infection Am. J. Clin. Nutr. 56 762–765

    Google Scholar 

  • Guenter P, Muurahein N, Simons G, Kosos KA, Cohan Gr, Rudenstein R & Turner JL (1993) Relationship between nutritional status, disease progression, and survival in HIV infection J. Acquir. Immune Defic. Syndr. 6 1130–1138

    CAS  PubMed  Google Scholar 

  • Kambwa MS, Fleming SC, Griffin GE, Caun K, Pinching AJ & Harris JRW (1990) Fat absorption and exocrine pancreatic function in HIV infection Q. J. Med. 273 49–56

    Google Scholar 

  • Kotler DP (1989) Malnutrition in HIV infection and AIDS AIDS 3 175–180

    Article  Google Scholar 

  • Kotler DP, Tierney AR, Wang J & Pierson RN (1989) Magnitude of body-cell-mass depletion and timing of death from wasting in AIDS Am. J. Clin. Nutr. 50 444–447

    Article  CAS  Google Scholar 

  • Macallan DC, Noble C, Baldwin C, Foskett M, McManus T & Griffin GE (1993) Prospective analysis of patterns of weight change in stage IV HIV infection Am. J. Clin. Nutr. 58 417–421

    Article  CAS  Google Scholar 

  • Macallan DC, McNurlan MA, Mime E, Calder AG & Gralick PJ (1995) Whole-body protein turnover from leucine kinetics and the response to nutrition in HIV infection Am. J. Clin. Nutr. 61 818–826

    Article  CAS  Google Scholar 

  • Melchior JC, Raguin G & Boulier A (1993) Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections Am. J. Clin. Nutr. 57 614–619

    Article  CAS  Google Scholar 

  • Pichard C, Slosman D, Hirschel B & Kyle U (1993) Bioimpedance analysis in AIDS patients: an improved method for nutritional follow up Clin. Res. 41 53 a

    Google Scholar 

  • Pichard C, Sudre P, Karsegard V, Yerly S, Slosman D, Delley V, Perrin L & Hirschel B (1998) A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega 3 fatty acids in HIV-infected patients AIDS 12 53–63

    Article  CAS  Google Scholar 

  • Shabert J & Wilmore DW (1996) Glutamine deficiency as a cause of human immunodeficiency virus wasting Med. Hypoth. 46 252–255

    Article  Google Scholar 

  • Shabert JK, Winslow C, Lacey J & Wilmore DW (1999) Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double blind controlled trial Nutrition 15 860–864

    Article  CAS  Google Scholar 

  • Süttmann U, Ockenga J & Schneider H (1996) Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support J. Am. Diet. Assoc. 96 565–569

    Article  Google Scholar 

  • Teng MN, Park BH & Koeppen HKW (1991) Long term inhibition of tumor growth by TNF in the abscence of cachexia of Tcell immunity Proc. Natl. Acad. Sci. USA 88 3535–3548

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to DA de Luis Román.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Luis Román, D., Bachiller, P., Izaola, O. et al. Nutritional treatment for acquired immunodeficiency virus infection using an enterotropic peptide-based formula enriched with n-3 fatty acids: a randomized prospective trial. Eur J Clin Nutr 55, 1048–1052 (2001). https://doi.org/10.1038/sj.ejcn.1601276

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1601276

Keywords

This article is cited by

Search

Quick links